Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
glycogen storage disease/triglyceride
Веза се чува у привремену меморију
Страна 1 од 114 резултати
Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A female presented in infancy with hypotonia, undetectable serum glucose, lactic acidosis, and triglycerides >5000 mg/dL. The diagnosis of type 1A glycogen storage disease was made via the result of a liver biopsy, which showed increased glycogen and absent glucose-6-phosphatase enzyme activity. The
Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Besides profound hypoglycemia with hyperlacticemia, glycogen storage disease type Ia (GSD Ia) presents hypertriglyceridemia that is often resistant to dietary treatment with cornstarch. The present study aimed to evaluate the effects of medium-chain triglycerides (MCT)--which are absorbed
Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Hypoketotic hypoglycaemia and hypertriglyceridaemia are biochemical hallmarks of glycogen storage disease (GSD) 1. Increased malonyl coenzyme A production which compromises oxidation of long-chain fatty acids via carnitine palmitoyltransferase (CPT) 1 inhibition plays a crucial role in the
Triglyceride clearing in glycogen storage disease.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Uncooked corn-starch (UCCS) has been the mainstay of therapy for the hepatic glycogen storage diseases (GSD) but is not always effective. A new starch (WMHMS) has demonstrated a more favourable short-term metabolic profile.
OBJECTIVE
To determine efficacy and safety of a new uncooked
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Glycogen storage disease type 1a (GSD-1a) is a metabolic disorder characterized by fasting-induced hypoglycemia, hepatic steatosis, and hyperlipidemia. The mechanisms underlying the lipid abnormalities are largely unknown. To investigate these mechanisms seven GSD-1a patients and four healthy
Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Glycogen storage disease (GSD) is a relatively rare inborn metabolic disorder, our study aims to investigate the genotypic and clinical feature of hepatic GSDs in China.
Methods:
Glycogen storage disease type VI: clinical course and molecular background.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Glycogen storage disease type VI (GSD-VI; also known as Hers disease, liver phosphorylase deficiency) is caused by mutations in the gene coding for glycogen phosphorylase (PYGL) leading to a defect in the degradation of glycogen. Since there are only about 40 patients described in literature, our
Preemptive living donor liver transplantation in glycogen storage disease Ia: case report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Even with substantial progress in the management of patients with glycogen storage disease type Ia (GSD-Ia), hepatic and renal complications may still develop during long-term follow-up. Herein, we report a case of preemptive living donor liver transplantation in a patient with GSD-Ia.
METHODS
The
[Home treatment of type I glycogenosis by continuous nocturnal gastric feeding].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Two children with type I glycogen-storage disease were treated at home with continuous nocturnal intragastric feeding, using a high glucose formula. The children were 6.5 years and 32 months old respectively when initiating treatment, and they have now been treated for 24 and 18 months. A high
Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Because glycogen storage disease type IA (GSD-IA) is characterized by recurrent episodes of hypoglycemia that promote a marked elevation in blood triglyceride levels, we evaluated plasma lipid levels in 12 patients with GSD-IA on a regular basis. Six of the 12 patients had plasma fatty acid
Nocturnal intragastric therapy in type I glycogen storage disease: effect on hormonal and amino acid metabolism.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The acute hormonal and amino acid responses to differing food substrates were examined in type 1 glycogen storage disease. Ingestion of a glucose load or a glucose-plus-beef meal caused an acute fall in the initially elevated plasma glucagon, alanine, proline, and lactate. Ingestion of beef alone
Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Objectives To investigate the clinical and genetic characteristics of children with glycogen storage disease type IIIa (GSD IIIa) and to explore the muscle involvement and manifestations of GSD IIIa patients. Methods The clinical data of 11 patients with GSD IIIa diagnosed by genetic testing from
Hepatic Glycogenosis In Children: Spectrum Of Presentation And Diagnostic Modalities.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Glycogen storage disease type Ia: frequency and clinical course in Turkish children.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The aim of this study was to determine the relative frequency of type Ia in glycogen storage disease (GSD) with prominent liver involvement and to determine its clinical and laboratory findings and prognosis in Turkish children. From 1980 to 1998, 45 out of 100 GSD patients (27 male) with liver
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
